BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 20734420)

  • 1. Adrenal incidentalomas: risk of adrenocortical carcinoma and clinical outcomes.
    O'Neill CJ; Spence A; Logan B; Suliburk JW; Soon PS; Learoyd DL; Sidhu SB; Sywak MS
    J Surg Oncol; 2010 Oct; 102(5):450-3. PubMed ID: 20734420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of concomitant malignancy in hyperfunctioning adrenal incidentalomas.
    Allan BJ; Thorson CM; Van Haren RM; Parikh PP; Lew JI
    J Surg Res; 2013 Sep; 184(1):241-6. PubMed ID: 23562276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk assessment in 457 adrenal cortical carcinomas: how much does tumor size predict the likelihood of malignancy?
    Sturgeon C; Shen WT; Clark OH; Duh QY; Kebebew E
    J Am Coll Surg; 2006 Mar; 202(3):423-30. PubMed ID: 16500246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Incidentally discovered adrenal masses in the Department of Internal Medicine, Endocrinology and Hemostatic Disorders, Medical University of Gdansk].
    Babińska A; Sworczak K; Siekierska-Hellmann M; Lewczuk A; Błaut K; Obołoiczyk L; Wiśniewski P; Zielonko J; Kaska L; Lachiński A
    Wiad Lek; 2006; 59(11-12):744-50. PubMed ID: 17427485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adrenocortical tumors in children.
    Ciftci AO; Senocak ME; Tanyel FC; Büyükpamukçu N
    J Pediatr Surg; 2001 Apr; 36(4):549-54. PubMed ID: 11283875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical management and clinical prognosis of adrenocortical carcinoma.
    Dong D; Li H; Yan W; Ji Z; Mao Q
    Urol Int; 2012; 88(4):400-4. PubMed ID: 22487802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival after adrenalectomy for stage I/II adrenocortical carcinoma (ACC): a retrospective comparative cohort study of laparoscopic versus open approach.
    Donatini G; Caiazzo R; Do Cao C; Aubert S; Zerrweck C; El-Kathib Z; Gauthier T; Leteurtre E; Wemeau JL; Vantyghem MC; Carnaille B; Pattou F
    Ann Surg Oncol; 2014 Jan; 21(1):284-91. PubMed ID: 24046101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of standardised reporting in adrenocortical carcinoma: a single centre clinicopathological review.
    Advani A; Vaikkakara S; Gill MS; Arun CS; Pearce SH; Ball SG; James RA; Lennard TW; Bliss RD; Quinton R; Johnson SJ
    J Clin Pathol; 2008 Aug; 61(8):939-44. PubMed ID: 18515402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of lymphadenectomy on the oncologic outcome of patients with adrenocortical carcinoma.
    Reibetanz J; Jurowich C; Erdogan I; Nies C; Rayes N; Dralle H; Behrend M; Allolio B; Fassnacht M;
    Ann Surg; 2012 Feb; 255(2):363-9. PubMed ID: 22143204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenal incidentaloma: does an adequate workup rule out surprises?
    Grogan RH; Mitmaker E; Vriens MR; Harari A; Gosnell JE; Shen WT; Clark OH; Duh QY
    Surgery; 2010 Aug; 148(2):392-7. PubMed ID: 20576282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of adrenocortical tumors in children.
    Hanna AM; Pham TH; Askegard-Giesmann JR; Grams JM; Iqbal CW; Stavlo P; Moir CR
    J Pediatr Surg; 2008 May; 43(5):843-9. PubMed ID: 18485950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laparoscopic resection of adrenal cortical carcinoma: a cautionary note.
    Gonzalez RJ; Shapiro S; Sarlis N; Vassilopoulou-Sellin R; Perrier ND; Evans DB; Lee JE
    Surgery; 2005 Dec; 138(6):1078-85; discussion 1085-6. PubMed ID: 16360394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors.
    Bilimoria KY; Shen WT; Elaraj D; Bentrem DJ; Winchester DJ; Kebebew E; Sturgeon C
    Cancer; 2008 Dec; 113(11):3130-6. PubMed ID: 18973179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic versus open adrenalectomy for adrenocortical carcinoma: surgical and oncologic outcome in 152 patients.
    Brix D; Allolio B; Fenske W; Agha A; Dralle H; Jurowich C; Langer P; Mussack T; Nies C; Riedmiller H; Spahn M; Weismann D; Hahner S; Fassnacht M;
    Eur Urol; 2010 Oct; 58(4):609-15. PubMed ID: 20580485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of MMP-1, MMP-8, MMP-9 serum levels in patients with adrenal tumors prior to and after surgery.
    Kołomecki K; Stepień H; Bartos M; Narebski J
    Neoplasma; 2001; 48(2):116-21. PubMed ID: 11478691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cost-effectiveness analysis of adrenalectomy for nonfunctional adrenal incidentalomas: is there a size threshold for resection?
    Wang TS; Cheung K; Roman SA; Sosa JA
    Surgery; 2012 Dec; 152(6):1125-32. PubMed ID: 22989893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adrenal carcinoma. Clinical and anatomopathological prognostic factors].
    Boneschi M; Erba M; Beretta L; Miani S; Bortolani EM
    Minerva Chir; 1998 Mar; 53(3):167-72. PubMed ID: 9617113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Operative intervention for recurrent adrenocortical cancer.
    Dy BM; Wise KB; Richards ML; Young WF; Grant CS; Bible KC; Rosedahl J; Harmsen WS; Farley DR; Thompson GB
    Surgery; 2013 Dec; 154(6):1292-9; discussion 1299. PubMed ID: 24238048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical management of advanced adrenocortical carcinoma: a 21-year population-based analysis.
    Tran TB; Liou D; Menon VG; Nissen NN
    Am Surg; 2013 Oct; 79(10):1115-8. PubMed ID: 24160811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of adrenocortical carcinomas identified incidentally.
    Rossfeld KK; Maithel SK; Prescott J; Wang TS; Fields RC; Weber SM; Sicklick JK; Yopp AC; Duh QY; Solorzano CC; Votanopoulos KI; Hatzaras I; Poultsides GA; Shirley LA;
    J Surg Oncol; 2018 Dec; 118(7):1155-1162. PubMed ID: 30332514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.